Danaher Corporation (NYSE:DHR) traded ~1% lower in the premarket on Tuesday as investors reacted to the life sciences company ...

Shares of Danaher Corp. DHR slipped 1.00% to $184.96 Monday, on what proved to be an all-around dismal trading session for ...

Danaher Corp. DHR) on Tuesday reported first-quarter profit of $954 million. The Washington-based company said it had profit of $1.32 per share.

DHR's first-quarter earnings are likely to have been aided by strength in the Biotechnology segment. However, weakness in the ...

Monday closed down -2.36%, the Dow Jones Industrials Index ($DOWI) (DIA) closed down -2.48%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -2.46%. June E-mini S&P futures (ESM25) are down -2.42%, ...

The in-vitro diagnostics market is projected to experience positive revenue growth due to factors such as the rising incidence of infectious diseases like COVID-19, an increasing prevalence of various ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Notable companies reporting before tomorrow’s open, with earnings consensus, include GE Aerospace (GE), consensus $1.27… Verizon (VZ), ...

The dental biomaterials market is projected to grow at a CAGR of ~8% over the forecast period. Major factors driving the growth include the increasing prevalence of dental disorders, growing demand ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...